EXPERTISE &
CONNECTIONS
Upcoming Events
LIST
FIELD
APR
15
TCR & CAR-T
MicroSummit
Quarter 1: Session 3
Tue, April 15, 2025
1:00 PM - 2:00 PM (Eastern US) + CET
A whirlwind tour of the latest in CAR-T and TCR-T drug development
131
APR
22
Radiopharma R&D
MicroSummit
Quarter 2: Session 1
Tue, April 22, 2025
1:00 PM - 2:00 PM (Eastern US)
Charting New Frontiers in Targeted Radiopharmaceuticals.
153
Past Events
MAR
25
Antibody-Drug Conjugates
MicroSummit
Quarter 1: Session 3
Tue, March 25, 2025
1:00 PM - 2:00 PM (Eastern US) + CET
The latest innovations in Antibody-Drug Conjugate drug development
146
MAR
4
AI in Drug Discovery
MicroSummit
Quarter 1: Session 2
Tue, March 4, 2025
1:00 PM - 2:00 PM (Eastern US)
Explore the latest breakthroughs where AI is driving forward new drug research paradigms
87
2024
Q4
Cytokine-Based Therapeutics
MicroSummit
Quarter 4: Session 3
Wed, Dec 18, 2024
1:00 PM - 1:00PM (Eastern US)
Engineering the next era of Targeted Immunotherapies
126
2024
Q3
Targeted Protein Degradation
MicroSummit
Quarter 3: Session 3
Thu, Nov 7, 2024
1:00 PM - 1:00PM (Eastern US) + CET (NEW)
Harnessing TPD and Induced Proximity for Next-Gen Therapeutics
134
2024
Q3
Cell Engager Therapeutics
MicroSummit
Quarter 3: Session 3
Wed, September 18, 2024
10:00 AM - 10:55 AM (Western US)
Unlocking the future of Advanced Therapeutics
121
2024
Q2
mRNA-based Therapeutics
MicroSummit
Quarter 2: Session 3
Tue, June 18, 2024
10:00 AM - 10:55 AM (Western US)
A whirlwind tour of the latest developments in mRNA drug development.
88
2024
Q2
Bispecific Antibody
MicroSummit
Quarter 2: Session 3
Thu, June 20, 2024
10:00 AM - 10:55 AM (Western US)
Accelerating Engineered Antibody Development
93
2024
Q1
Antibody-Drug Conjugates
MicroSummit
Quarter 1: Session 3
Wed, March 27, 2024
10:00 AM - 10:55 AM (Western US)
The latest developments in Antibody Drug Conjugate drug development
92
2024
Q1
CAR-T & TCR
MicroSummit
Quarter 1: Session 3
Tue, March 26, 2024
10:00 AM - 10:55 AM (Western US)
A whirlwind tour of the latest developments in CAR-T and TCR-T drug development with an emphasis on Solid Tumors
89
2023
Q4
Blood Cancer
R&D MicroSummit
Quarter 4: Session 3
Wed, December 20, 2023
10:00 AM - 10:55 AM PDT
A whirlwind tour of the latest developments in Precision Medicine for Hematological drug development
86
2024
Q3
Liquid Biopsy
R&D MicroSummit
Quarter 3: Session 3
Thu, September 28, 2023
10:00 AM - 10:55 AM PDT
Rapid insights on Biomarker strategies, challenges and solutions in Precision oncology and comprehensive platforms in Liquid Biopsy.
88
2023
Q3
Immuno-Oncology
R&D MicroSummit
Quarter 3: Session 3
Tue, September 26, 2023
10:00 AM - 10:55 AM PDT
Novel Immunotherapies and Leading Strategies with rapid insights from Large Pharma and Biotech
